A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.114833 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Cuizhen Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cetuximab, Machine Learning, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
There is significant individual variation in the efficacy of cetuximab for the treatment of colorectal cancer (CRC). However, effective models to predict treatment outcomes are still lacking in clinical practice.
Methods
Datasets (GSE106582 and GSE83889) were used to identify differentially expressed genes (DEGs) in CRC by the 'Limma' package in R software. Hypoxia-related genes were retrieved from the Molecular Signatures Database and cross-referenced with CRC DEGs. Protein expression levels were verified using immunohistochemistry (IHC) data from the Human Protein Atlas (HPA), and prognostic significance was assessed through the Kaplan-Meier plotter platform. Additionally, pathway and immune infiltration analyses were performed using the GSCA platform. We also successfully constructed a prediction model for cetuximab treatment response using the K-nearest neighbors (KNN) algorithm in GSE108277 dataset, in which the feature selection was performed through the permutation importance method.
Results
Analysis of GSE106582 and GSE83889 identified 417 overlapping DEGs by comparing cancer tissues with normal controls, including 16 hypoxia-related genes. 6 genes (BGN, DDIT4, MIF, SLC2A1, STC2, and TGFBI) were upregulated, and 10 genes (CA12, CITED2, MT1E, MT2A, NEDD4L, PCK1, PLAC8, PPARGC1A, SELENBP1, and SRPX) were downregulated in CRC. Survival analysis revealed that the 16 hypoxia-related DEGs were linked to the survival outcomes of CRC patients. Pathway analysis indicated that these genes were almost involved in EMT, cell cycle, and RTK pathways. Furthermore, these genes play a role in the infiltration of immune cells and may regulate the immune microenvironment. A prediction model for cetuximab response was developed, based on 10 key genes (CA12, DDIT4, MIF, MT2A, NEDD4L, PLAC8, SELENBP1, SLC2A1, SRPX, and TGFBI) and dataset from GSE108277. The model demonstrated robust performance with an accuracy of 0.9500, precision of 0.8378, recall of 1.0000, F1-score of 0.9118, and a receiver operating characteristic-area under the curve (ROC-AUC) of 0.9663.
Conclusion
Our study identifies 10 hypoxia-related DEGs as key players in CRC progression and cetuximab response. And we successfully developed a predictive model to forecast the response of CRC patients to cetuximab treatment. This study will provide valuable biomarkers for CRC prognosis and help guide more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai, 200040, China.
- Key Laboratory of Big Data Intelligent Computing, Chongqing University of Posts and Telecommunications, Chongqing, 400065, China.
- Department of Pharmacy, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, 466 Middle Xingang Road, Guangzhou, 510317, China.
Zitieren
APA
Zhang, C., Niu, W., Zhang, J., Zheng, Y., Chen, Z., Zhang, F., & Qiu, X. (2025). A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.114833
Vancouver
Zhang C, Niu W, Zhang J, Zheng Y, Chen Z, Zhang F, et al. A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.114833
BibTeX
@article{Zhang2025,
author = {Zhang, Cuizhen and Niu, Wanjie and Zhang, Jiangtao and Zheng, Yingyi and Chen, Zhiru and Zhang, Fali and Qiu, Xiaoyan},
title = {A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.114833}
}
EUVIMED